Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel CDK9 inhibitor with good antiproliferative activity in hematologic cancer models

July 20, 2022

AZD-1390 induces dramatic recovery after spinal cord injury in preclinical models

July 20, 2022

Hepsin contributes to metastasis and thrombosis in patients with CRC, study finds

July 20, 2022

Novel HDAC3 inhibitor shows antitumor activity in 4T1-Luc xenograft mouse model

July 19, 2022

Researchers unveil novel markers involved in pulmonary embolism

July 19, 2022

Organoid efficacy data leads to approval of clinical trial of rare disease drug

July 19, 2022

Targeting GABA-transported GAT-3 in astrocytes reduces negative outcomes of brain injury

July 19, 2022

Chinese researchers synthesize new vasopressin receptor antagonists

July 19, 2022

Jiangsu Tasly Diyi Pharmaceutical presents new FXR agonists

July 19, 2022

Abbisko Therapeutics describes new GTPase KRAS inhibitors

July 19, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...